HIV and Pregnancy
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (8/12/2021)
Original Editor - Simisola Ajeyalemi
Top Contributors - Simisola Ajeyalemi and Kim Jackson
Introduction[edit | edit source]
Human immunodeficiency virus (HIV) transmission from mother to child can happen in utero, during labor, or after birth through breastfeeding. The World Health Organization estimates that without intervention, the rate of HIV transmission from an HIV-positive mother to her child during pregnancy, labor, delivery, or breastfeeding ranges from 15% to 45%. However, the risk of mother-to-child transmission has been significantly reduced as a result of early detection, effective antiretroviral therapy (ART), appropriate delivery management, and breastfeeding avoidance.
Antiretroviral Drugs in Pregnancy[edit | edit source]
Dolutegravir (DTG) is the preferred antiretroviral (ARV) medication for pregnant women, and women trying to conceive. This follows evidence that Dolutegravir is associated with a low risk of neural tube defects, as well as long-term viral load reduction, which is critical for maternal health and preventing perinatal HIV transmission.[2]
Sub Heading 3[edit | edit source]
Resources[edit | edit source]
References[edit | edit source]
- ↑ HIV / AIDS and Pregnancy - What You Need To Know. Available from https://www.youtube.com/watch?v=bZpbrYtLhRM
- ↑ Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Available from https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines Accessed 8th December 2021
